These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 21005323)
1. CHEMOTHERAPY of tuberculosis and leprosy. Ther Notes; 1945 Jun; 52():87-94. PubMed ID: 21005323 [No Abstract] [Full Text] [Related]
2. [Chemotherapy of tuberculosis and leprosy]. SUPNIEWSKI J Postepy Hig Med Dosw; 1952; 5():7-28. PubMed ID: 12993611 [No Abstract] [Full Text] [Related]
3. The position of leprosy and tuberculosis in experimental chemotherapy. SCHNITZER RJ Antibiot Chemother; 1961; 9():145-88. PubMed ID: 13748314 [No Abstract] [Full Text] [Related]
4. Combined chaulmoograte and sulphone treatment of leprosy and tuberculosis. ROGERS L Lancet; 1948 Apr; 1(6501):515-7. PubMed ID: 18906771 [No Abstract] [Full Text] [Related]
5. [Preparation of substances inhibiting the development of bacterial resistance during therapy of tuberculosis and active in therapy of leprosy]. OERIU S Stud Cercet Inframicrobiol; 1955; 6(1-2):187-97. PubMed ID: 13281739 [No Abstract] [Full Text] [Related]
6. Immunotherapy for leprosy and tuberculosis. Stanford JL Prog Drug Res; 1989; 33():415-48. PubMed ID: 2687943 [No Abstract] [Full Text] [Related]
7. Mercaptan compounds in leprosy and tuberculosis. INNES JR Med Dig; 1960 Feb; 28():77-83. PubMed ID: 13717763 [No Abstract] [Full Text] [Related]
8. ISONICOTINIC hydrazines in tuberculosis. Int J Lepr; 1952; 20(2):249-54. PubMed ID: 12990240 [No Abstract] [Full Text] [Related]
9. Lymphocytotherapy for pseudomonas infections, tuberculosis, and leprosy. Moore GE Lancet; 1969 Oct; 2(7623):746. PubMed ID: 4186191 [No Abstract] [Full Text] [Related]
10. Problem-based learning for tuberculosis and leprosy supervisors. Alabi GA; Gerritsma J; Maude G; Parry E World Health Forum; 1996; 17(4):411-4. PubMed ID: 9060247 [TBL] [Abstract][Full Text] [Related]
11. Tuberculosis and leprosy: potential novel drugs and vaccines against Mycobacterium. A Symposium held at Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia, July 3-5, 2002. Proceedings. Tuberculosis (Edinb); 2004; 84(1-2):1-130. PubMed ID: 14670339 [No Abstract] [Full Text] [Related]
12. [Pharmacology, toxicology and mechanism of action of some chemotherapeutics]. REBOLLEDO LARA M Prensa Med Mex; 1953; 18(8-9):231-8. PubMed ID: 13120730 [No Abstract] [Full Text] [Related]
14. Tuberculosis and leprosy: a comparison. Pattyn SR Acta Leprol; 1978; (73):3-11. PubMed ID: 108911 [No Abstract] [Full Text] [Related]
15. Interim notes on the therapeutics of bismuth, antimony, zinc, iron, and copper arsanilate in the treatment of malignant disease, syphilis, yaws, leprosy, tuberculosis, whooping cough and some minor complaints in the African. SHIRCORE JO East Afr Med J; 1946 Aug; 23(8):226-38. PubMed ID: 20278571 [No Abstract] [Full Text] [Related]
17. [Isonicotinic acid hydrazide in cutaneous tuberculosis and leprosy]. BERTACCINI G Ann Ital Dermatol Sifilogr; 1953; 8(1):5-9. PubMed ID: 13058248 [No Abstract] [Full Text] [Related]
18. Modern leprosy treatment. AUSTIN CJ Lepr Rev; 1954 Oct; 25(4):174-8. PubMed ID: 13222922 [No Abstract] [Full Text] [Related]
19. [Early results of isonicotinic acid hydrazide therapy of cutaneous and testicular tuberculosis and of leprosy]. GRASSI A Rass Dermatol Sifilogr; 1952; 5(2):107-10. PubMed ID: 13027592 [No Abstract] [Full Text] [Related]
20. Meeting report: Tuberculosis research in China; a historic meeting; China-Japan-US Tuberculosis International Seminar and US-Japan Cooperative Medical Science Program 42nd Tuberculosis and Leprosy Research Conference, 2007. Sugawara I; McMurray D Tuberculosis (Edinb); 2008 May; 88(3):268-70. PubMed ID: 18065269 [No Abstract] [Full Text] [Related] [Next] [New Search]